Kyorin Pharmaceutical Co (TSE:4569) EPS (Basic) : 円74.27 (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co EPS (Basic)?

Kyorin Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was 円37.57. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was 円74.27.

Kyorin Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2023 was 円37.57. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円74.27.

Kyorin Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2023 was 円49.19. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 67.27.

During the past 12 months, Kyorin Pharmaceutical Co's average EPS without NRIGrowth Rate was -32.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was -13.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -7.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was -9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Kyorin Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 55.60% per year. The lowest was -18.60% per year. And the median was -2.50% per year.

Kyorin Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Kyorin Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co EPS (Basic) Chart

Kyorin Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EPS (Basic)

Get a 7-Day Free Trial

104.68

107.35

106.99

68.62

82.44

Kyorin Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															54.71	6.04	11.81	18.85	37.57

Kyorin Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Kyorin Pharmaceutical Co's Basic EPS for the fiscal year that ended in Mar. 2023 is calculated as

Basic EPS (A: Mar. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(4723	-	0)	/	57.303
	=	82.42

Kyorin Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2157	-	0)	/	57.449
	=	37.55

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円74.27

Kyorin Pharmaceutical Co (TSE:4569) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Kyorin Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyorin Pharmaceutical Co (TSE:4569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311

Website

https://www.kyorin-pharm.co.jp

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co (TSE:4569) Headlines

No Headlines